Physician profile
Eric J Levene
NPI 1750458444
$2,633.23
in general payments reported to CMS, 2019-2025
21 companies · $493 in 2025
The $493 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $259 · 2021: $458 · 2022: $412 · 2023: $254 · 2024: $246 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $473.58 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $349.54 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $333.33 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sobi, INC | $284.71 | 2019-2023 | |
| Glaxosmithkline, LLC. | $187.13 | 2019-2022 | |
| Seqirus USA INC | $181.56 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
| Hologic Sales and Service, LLC | $168.31 | 2019-2025 | Aptima |
| Genentech USA, INC. | $109.21 | 2019-2021 | |
| Sanofi Pasteur INC. | $107.02 | 2021-2025 | |
| Cranial Technologies, INC | $91.74 | 2019-2023 | Doc Band |
| Cumberland Pharmaceuticals, INC. | $67.19 | 2025 | Kristalose |
| Alk-Abello, INC | $52.22 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $49.09 | 2024-2025 | Vpriv |
| Ultragenyx Pharmaceutical INC. | $33.98 | 2020 | |
| Aytu Biopharma, INC. | $24.94 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $23.28 | 2025 | Neffy |
| Shire North American Group INC | $22.95 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.71 | 2023 | |
| Abbvie INC. | $21.00 | 2025 | |
| Bavarian Nordic A/S | $16.26 | 2025 | Vaxchora, Vivotif |
| Alexion Pharmaceuticals, INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Levene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.